Alumni of the Department of Biostatistics make an impact in all areas of public health. Here are profiles of a few of our notable alumni.
John Lachin (ScD ’72) is professor of biostatistics and epidemiology at the George Washington University (GWU) School of Public Health and Health Services in Washington, D.C. He served as director of the Biostatistics Center at GWU from 1988 to 2000, and led the development of the GWU Graduate Programs in Biostatistics and Epidemiology. Currently, he is principal investigator of the Coordinating Centers for the Epidemiology of Diabetes Interventions and Complications and The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study, and is coinvestigator for the Diabetes Prevention Program Outcomes Study. Lachin is a fellow of the Society for Clinical Trials, American Statistical Association, and the Royal Statistical Society, and a member of the International Statistical Institute.
Myunghee Cho Paik (PhD ’87), who until recently was a professor of biostatistics and director of the DrPH program at the Columbia University Mailman School of Public Health in New York, is now at Seoul National University in South Korea. Paik is coauthor, along with Joseph L. Fleiss and Bruce Levin, of the third edition of Statistical Methods for Rates and Proportions (Wiley-Interscience, 2003).
Daniel Schaid (MS ’81, PhD ’86) is a professor in the Biostatistics Section of the Mayo Clinic Department of Health Sciences Research in Rochester, Minn. From 1986–92, Schaid worked in cancer clinical trials and genetic studies at the Mayo Clinic, and since his sabbatical leave from 1992–93 to work on statistical genetics problems, he has been investigating statistical methods for genetic linkage and association studies. His research areas include quantitative methods for genetic epidemiology, collaborative genetic analyses, prostate cancer, pharmacogenetics of phase II drug-metabolizing enzymes, and Alzheimer's disease.
John Scott (PhD ’08) is acting deputy director of the Division of Biostatistics at the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) in Washington, D.C. Prior to this position, he was acting team leader for hematology and mathematical statistician in the Therapeutics Evaluation Branch at CBER. He also worked as a statistician at Western Psychiatric Institute and Clinic of UPMC, primarily in clinical trials in adult affective disorders, behavioral pharmacology, and sleep medicine.